公司概覽
業務類別 --
業務概覽 Athersys Inc is a biotechnology company engaged in the field of regenerative medicine. It consists of research, clinical development, manufacturing, and manufacturing process development activities. The firm's main product is Multistem cell therapy. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.
公司地址 3201 Carnegie Avenue, Cleveland, OH, USA, 44115-2634
電話號碼 +1 216 431-9900
傳真號碼 +1 216 361-9495
公司網頁 https://www.athersys.com
員工數量 24
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Maia A. Hansen Chief Operating Officer -- 03/04/2023
Mr. Daniel A. Camardo, M.B.A. Chief Executive Officer and Director -- 17/08/2023
Ms. Kasey Rosado Interim Chief Financial Officer and Principal Accounting Officer -- 03/04/2023
 
董事會成員
董事會 職務 更新日期
Mr. Jack L. Wyszomierski, M.S. Independent Director 17/08/2023
Ms. Jane Wasman, J.D. Chairman of the Board 17/08/2023
Mr. Daniel A. Camardo, M.B.A. Chief Executive Officer and Director 17/08/2023
Mr. Joseph Nolan Director 05/01/2023
Ms. Neema Mayhugh Director 11/08/2023
 
所屬ETF (更新日期: 07/11/2026 03:24)
代號 名稱 佔比% ▼ 持有日期
GUGGuggenheim Active Allocation Fund0.0002%31/08/2026
ITOTiShares Core S&P Total US Stock Mkt ETF<0.000001%06/03/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.